Skip to main content
Clinical Trials/NCT00660712
NCT00660712
Completed
N/A

Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey

AstraZeneca1 site in 1 country1,018 target enrollmentMarch 2008

Overview

Phase
N/A
Intervention
Not specified
Conditions
Bipolar Disorder
Sponsor
AstraZeneca
Enrollment
1018
Locations
1
Primary Endpoint
Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.
Status
Completed
Last Updated
16 years ago

Overview

Brief Summary

A registry study to identify the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

Registry
clinicaltrials.gov
Start Date
March 2008
End Date
March 2009
Last Updated
16 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients previously or currently diagnosed with bipolar disorder
  • Patients (or any of their relatives) who give a written informed consent.

Exclusion Criteria

  • Patients who were previously included in this study.

Outcomes

Primary Outcomes

Identification of the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.

Secondary Outcomes

  • Identification of treatment modalities selected according to the disease phase
  • Identification of the number of first degree relatives diagnosed with bipolar disorder
  • Evaluation of the relationship between patient and disease characteristics
  • Evaluation of co-morbid psychiatric diseases
  • Evaluation of the time period that elapsed since the diagnosis of bipolar disorder

Study Sites (1)

Loading locations...

Similar Trials